Filing Flows

Filing Flows › Bausch Health Companies (BHC) › Q1 2026

Bausch Health Companies (BHC) Q1 2026 earnings results (first quarter 2026)

10-Q filed Apr 30, 2026

Bausch Health Companies (BHC) reported revenue of $2.5B for the first quarter 2026 (Q1 2026), +12% from a year earlier and -10% from the quarter before. Operating margin was -37.6%, net loss $1.4B (56.7% of revenue).

Revenue$2.5B
Year over year+12%
Quarter over quarter-10%
Operating margin-37.6%
Net earnings−$1.4B

Bausch Health Companies, Q1 2026: revenue $2.5B (+12% year over year), operating margin -37.6%, net loss $1.4B, operating cash flow $230M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$2.5B-10%+12%
Operating profit−$950M-300%-444%
Net earnings−$1.4B——
Operating cash flow$230M-54%+9%
Free cash flow$121M-70%+26%

What changed

Revenue was $2.5B in Q1 2026, up 12% year over year and down 10% from the previous quarter. Product sales was the largest line at 99% of revenue. Product sales added $0.27B year over year (up 12%), 103% of the total change. Other revenues declined 25%.

Operating costs exceeded revenue by $0.9B, an operating margin of -37.6%. Total costs grew 75% against revenue growth of 12%. The fastest-growing cost line was Other operating costs (+152%). The quarter ended with a net loss of $1.4B, wider than the previous quarter's $0.10B loss. Minority interests bore $0.01B of it: to shareholders the quarter was a loss of $1.4B.

Operating cash flow was $0.23B (up 9% year over year). Non-cash charges added back $0.29B of depreciation and amortization and $0.05B of share-based compensation. Working capital and other items added $1.3B. Capital expenditures of $0.11B left free cash flow of $0.12B.

Questions

What was Bausch Health Companies' revenue in the first quarter 2026?

Bausch Health Companies (BHC) reported revenue of $2.5B for the first quarter 2026 (Q1 2026), +12% from a year earlier and -10% from the quarter before.

Was Bausch Health Companies profitable in the first quarter 2026?

Operating loss was $950M (-37.6% of revenue) and net loss $1.4B.

Open the interactive Sankey →

Source: Bausch Health Companies 10-Q on SEC EDGAR.